Sage Journals: Discover world-class research

Free access

Research article

First published 2021-06-25

Association of ERα-36 expression with the de novo resistance of tamoxifen in ER-positive breast cancer

Amir Juliansyah, Septiman Rahman, Indra Indra [...]

Breast Disease

Open access

Research article

First published 2021

FGFR1 Is Associated With Tamoxifen Resistance and Poor Prognosis of ER-Positive Breast Cancers by Suppressing ER Protein Expression

Qing Lv, Shiming Guan, Mingjie Zhu [...]

Technology in Cancer Research & Treatment

Open access

Review article

First published 2023

Neoadjuvant endocrine therapy in ER-positive breast cancer: evolution,indication,and tailored treatment strategy

Hyehyun Jeong, Sung-Bae Kim

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2018-09-11

The relationship between serum E2 levels and recurrence in premenopausal,ER-positive breast cancer patients: A retrospective study

Haruko Takuwa, Shigehira Saji, Masahiro Takada [...]

Breast Disease

Open access

Research article

First published 2023

ER status conversion and subsequent treatment: an assessment of negative ER expression detected by 18F-FES PET in metastatic breast cancer patients with ER-positive primary tumors

Shuhui You, Yizhao Xie, Mengjing Ji [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

CanAssist Breast-based prognostication in low-intermediate estrogen receptor positive (ER 1%–20% ) early-stage breast cancer patients helps guide treatment decisions

Susmita Ghosh, Tejal Deepak Durgekar, Manvi Sunder [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022-7

The Relationship Between the Tumor Cell Expression of Hypoxic Markers and Survival in Patients With ER-positive Invasive Ductal Breast Cancer

Suad A.K. Shamis, Jean Quinn, Elizabeth E.A. Mallon [...]

Journal of Histochemistry & Cytochemistry

Retricted access

Review article

First published 2024-8

Elacestrant for ER-Positive HER2-Negative Advanced Breast Cancer

Elizabeth Hageman, Mia E. Lussier

Annals of Pharmacotherapy

Open access

Review article

First published 2018

Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper

Nicolò Matteo Luca Battisti, Nienke De Glas, Mina S. Sedrak [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2023-9

CYP2C19*17 association with higher plasma 4-hydroxy tamoxifen in Pakistani (estrogen-positive) breast cancer patients

Muhammad Usman Tareen, Sana Riaz, Saima Shakil Malik [...]

Experimental Biology and Medicine

Search results